- Record: found
- Abstract: not found
- Article: not found
1416TiP CodeBreak 200: a phase III multicenter study of sotorasib (AMG 510), a KRAS (G12C) inhibitor, versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC) harboring KRAS p. G12C mutation
M Reck, A Spira, B Besse, J Wolf, F. Skoulidis, H Borghaei, J. WOLF, K. GOTO, K. PARK, F Griesinger, E Felip, M. BOYER, C.H. Barrios, G. Goss, H. Yang, C. Obiozor, S.S. Ramalingam, K Goto, K Park
2020
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Comments
Comment on this article
scite_
0
0
0
0
Smart Citations0
0
0
0
Citing PublicationsSupportingMentioningContrasting
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.